Physical therapy in the prevention of musculoskeletal sequelae in patients undergoing chronic psychotropic drug use: A literature review

Authors

DOI:

https://doi.org/10.62827/fb.v26i6.1128

Keywords:

Psychotropic Drugs; Physical Therapy Modalities; Physical Therapy Services; Functional Medicine.

Abstract

Introduction: Chronic use of psychotropic drugs is associated with significant musculoskeletal repercussions, including reduced strength, postural changes, loss of bone density, increased risk of falls, and functional impairment. These changes result from the interaction between pharmacological effects, biopsychosocial factors, and secondary sedentary lifestyle, requiring an interdisciplinary approach that integrates physical therapy, medicine, and educational strategies to prevent and minimize sequelae. Objective: We analyzed the impact of the integration of physical therapy and medicine in the prevention and management of musculoskeletal sequelae in patients undergoing prolonged use of psychotropic drugs, identifying effective rehabilitation strategies, functional protocols, and collaborative care mechanisms. Methods: This is a descriptive and analytical literature review based on national and international publications obtained from the Virtual Health Library (VHL), Latin American and Caribbean Health Sciences Literature (LILACS), PubMed, and Scopus databases. Eleven studies published between 2016 and 2025 were included, selected for their relevance to the musculoskeletal effects of psychotropic drugs, risk of falls, bone loss, motor changes, and interdisciplinary approaches aimed at preventing these outcomes. Results:  Evidence suggests that structured programs involving resistance exercises, balance training, lower limb strengthening, motor reeducation, and health education significantly reduce the functional impact of psychotropic drugs. Interventions associated with medical follow-up, including monitoring of side effects, pharmacological adjustment, and metabolic and bone risk assessment, have been shown to prevent falls, minimize bone mineral density loss, and improve mobility. Multidisciplinary models, educational support, and continuity of care strategies, including telerehabilitation, have proven to be decisive for adherence, engagement, and maintenance of results. Conclusion: An interdisciplinary approach between physical therapy and medicine is essential to prevent musculoskeletal sequelae in chronic users of psychotropic drugs. Individualized, evidence-based protocols combining therapeutic exercises, continuous clinical monitoring, and biopsychosocial strategies promote the preservation of functionality, postural stability, and autonomy. This collaborative model reaffirms the importance of professional integration and patient-centered care as essential pillars of contemporary musculoskeletal rehabilitation.

Author Biographies

  • Marcele Zago Marcolan, UVV

    Graduada em Medicina na Universidade Vila Velha (UVV), Vila Velha, ES, Brasil

  • Julia Torres Rocha , UVV

    Graduada em Medicina na Universidade Vila Velha (UVV), Vila Velha, ES, Brasil 

  • Anna Flavia Vieira Pinto, UVV

    Graduada em Medicina na Universidade Vila Velha (UVV), Vila Velha, ES, Brasil 

  • Camila Pereira Morbelli , UVV

    Graduada em Medicina na Universidade Vila Velha (UVV), Vila Velha, ES, Brasil 

  • Maria Vitória Guerini Novaes , UVV

    Graduada em Medicina na Universidade Vila Velha (UVV), Vila Velha, ES, Brasil 

  • Isadora Schwartz Meireles , UVV

    Graduada em Medicina na Universidade Vila Velha (UVV), Vila Velha, ES, Brasil 

  • Virginia Modenesi, UVV

    Graduada em Medicina na Universidade Vila Velha (UVV), Vila Velha, ES, Brasil 

  • Júlia Moreno Castro de Oliveira, UVV

    Graduada em Medicina na Universidade Vila Velha (UVV), Vila Velha, ES, Brasil 

References

O’Donnell D, Briggs R, Aiken FM, Kelly RA, Moriarty F, O’Donovan D, et al. Association between psychotropic medication use and gait and mobility impairment in community-dwelling older people: data from The Irish Longitudinal Study on Ageing (TILDA). J Gerontol A Biol Sci Med Sci [Internet]. 2025 [cited 2025 Dec 03];80(5):glae263. Available from: https://academic.oup.com/biomedgerontology/article/80/5/glae263/7877097. doi:10.1093/gerona/glae263 OUP Academic

Kang S, Han M, Kim EH, Boo YJ, Park CI, Jung I. Use of serotonin reuptake inhibitors and risk of subsequent bone loss: longitudinal cohort study. Sci Rep [Internet]. 2025 [cited 2025 Dec 03]. Available from: https://www.nature.com/articles/s41598-024-80471-6. doi:10.1038/s41598-024-80471-6 Nature

Guo M, Tao S, Xiong Y, Li J, Chen Z, Wang Y, et al. Comparative analysis of psychiatric medications and their association with falls and fractures: a systematic review and network meta-analysis. Psychiatry Res [Internet]. 2024 [cited 2025 Dec 02];338:115974. Available from: https://www.sciencedirect.com/science/article/pii/S0165178124002592. doi:10.1016/j.psychres.2024.115974

Hu J, Smith T, López A, Fernández M, Santos R, Müller P, et al. Osteoporosis and fracture risk associated with novel antidepressants: a systematic review and meta-analysis. Actas Españolas Psiquiatr [Internet]. 2024 [cited 2025 Dec 02];52(3):334-346. Available from: https://actaspsiquiatria.es/index.php/actas/article/view/1560. doi:10.62641/aep.v52i3.1560

Rozing MP, Janssen P, Verhoeven AC, de Jong H, Visser J, Dekker J, et al. Use of hypnotic-sedative medication and risk of falls and fractures in older adults. Acta Psychiatr Scand [Internet]. 2023 [cited 2025 Nov 30]. Available from: https://onlinelibrary.wiley.com/doi/10.1111/acps.13610. doi:10.1111/acps.13610

Mercurio M, Rossi L, Bianchi S, Ferrari G, Conte A, De Luca V, et al. The use of antidepressants is linked to bone loss: a systematic review and meta-analysis. Orthop Rev [Internet]. 2022 [cited 2025 Dec 02];14(1):38564. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9568413/. doi:10.4081/or.2022.38564

de Filippis R, Santoro L, Russo F, Esposito A, Romano M, Pirozzi C, et al. Antidepressants and vertebral and hip fracture risk. Healthcare [Internet]. 2022 [cited 2025 Dec 02];10(5):803. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9140335/. doi:10.3390/healthcare10050803

Treves N, Liperoti R, Cattel C, Onder G, Cherubini A, Logroscino G, et al. Z-drugs and risk for falls and fractures in older adults: a systematic review and meta-analysis. Age Ageing [Internet]. 2018 [cited 2025 Dec 02];47(2):201-209. Available from: https://academic.oup.com/ageing/article/47/2/201/4564456. doi:10.1093/ageing/afx170

Schweiger JU, Müller H, Hoffmann T, Becker R, Fischer P, Grünwald J, et al. The use of antidepressive agents and bone mineral density in women: a meta-analysis. Int J Environ Res Public Health [Internet]. 2018 [cited 2025 Dec 02];15(7):1373. Available from: https://www.mdpi.com/1660-4601/15/7/1373. doi:10.3390/ijerph15071373

Bolton JM, Robinson J, Sareen J, Bolton E, Crawford A, Patten S, et al. Association of mental disorders and related medication use with risk for major osteoporotic fractures. JAMA Psychiatry [Internet]. 2017 [cited 2025 Dec 02];74(4):387-395. Available from: https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2618262. doi:10.1001/jamapsychiatry.2017.0077

Boldt AS, Hatton A, Grund S, Schmidt H, Peters K, Meyer E, et al. The impact of psychotropic medications on muscle function, fall risk, and bone density: implications for rehabilitation. Curr Opin Psychiatry [Internet]. 2016 [cited 2025 Dec 01];29(5):380-387. Available from: https://journals.lww.com/copri/fulltext/2016/09000/the_impact_of_psychotropic_medications_on_muscle.4.aspx. doi:10.1097/YCO.0000000000000272

Published

2025-12-30

How to Cite

Physical therapy in the prevention of musculoskeletal sequelae in patients undergoing chronic psychotropic drug use: A literature review. (2025). Fisioterapia Brasil, 26(6), 2902-2912. https://doi.org/10.62827/fb.v26i6.1128

Most read articles by the same author(s)